 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol
IDs
|
|
|
| |
A Phase I/II Study of the Photon Radiosurgery System
|
|
|
|
Phase II, Phase I
|
|
|
|
CNS 0201
NCT00179907
|
|
| |
Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors
|
|
|
|
Phase II, Phase I
|
|
|
|
R01 CA 89395-01
Topotecan, Brain Tumors, Intracerebral Clysis, NCT00452959
|
|
| |
A Multi-Center Phase I Study of AP23573 in Pediatric Patients With Advanced Solid Tumors
|
|
|
|
Phase II, Phase I
|
|
|
|
SUN08-01
NCT00704054
|
|
| |
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
|
|
|
|
Phase II, Phase I
|
|
|
|
CHNMC-07053
07053, CA180 121, NCT00788125
|
|
| |
Antineoplaston Therapy in Treating Children With Brain Tumors
|
|
|
|
Phase II
|
|
|
|
BC-BT-10
NCT00003458
|
|
| |
Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
|
|
|
|
Phase II
|
|
|
|
BC-BT-22
NCT00003476
|
|
| |
A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects
|
|
|
|
Phase II
|
|
|
|
RT1
NCT00187226
|
|
| |
Gemcitabine and Oxaliplatin in Treating Young Patients With Refractory or Relapsed Solid Tumors
|
|
|
|
Phase II
|
|
|
|
CCLG-NAG-2007-01
ITCC-004-GEMOX, CCLG-IGR-1205, EU-20745, EUDRACT-2006-001065-41, NCT00407433
|
|
| |
Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-Cis-Retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors
|
|
|
|
Phase II
|
|
|
|
NYU 05-40 H12853
PBMTC ONC-032P, NCT00528437
|
|
| |
Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
|
|
|
|
Phase II
|
|
|
|
3368
NCT00576537
|
|
